CTT Pharmaceutical Holdings, Inc.'s Form 4 filing
CTT Pharmaceutical Holdings, Inc. (CTTH) · filed Mar 10, 2025
- Accession no.
- 0001035422-25-000002
- Filed
- Mar 10, 2025, 9:21 AM ET
- Trade date
- Mar 7, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $1.08K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| CTT Pharmaceutical Holdings, Inc.CIK 0001035422 | Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | CTTH | PPurchaseAcquired | +11,950 | $0.09 | +$1,075.5 | 6,569,506 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.